Dictyostelium phenylalanine hydroxylase is activated by its substrate phenylalanine  by Kim, Hye-Lim et al.
FEBS Letters 586 (2012) 3596–3600journal homepage: www.FEBSLetters .orgDictyostelium phenylalanine hydroxylase is activated by its substrate phenylalanine
Hye-Lim Kim a, Mi-Bee Park a, Yumin Kim a, Yun Gyeong Yang a, Soo-Woong Lee b, Ningning Zhuang c,d,
Kon Ho Lee d,e, Young Shik Park a,⇑
a FIRST Research Group, School of Biological Sciences, Inje University, Kimhae 621-749, Republic of Korea
bAdvanced Research Center for Multiple Myeloma, College of Medicine, Inje University, Busan 614-735, Republic of Korea
cDivision of Applied Life Science (BK21 Program), Gyeongsang National University, Jinju 660-701, Republic of Korea
d PMBBRC, Gyeongsang National University, Jinju 660-701, Republic of Korea
eDepartment of Microbiology, School of Medicine, Gyeongsang National University, Jinju 660-751, Republic of Korea
a r t i c l e i n f oArticle history:
Received 19 June 2012
Revised 8 September 2012
Accepted 10 September 2012
Available online 24 September 2012
Edited by Miguel De la Rosa
Keywords:
Dictyostelium
Phenylalanine hydroxylase
Enzyme kinetics
Regulatory domain
Protein stability0014-5793/$36.00  2012 Federation of European Bio
http://dx.doi.org/10.1016/j.febslet.2012.09.008
Abbreviations: BH4, L-erythro-tetrahydrobiopterin;
(D-threo-tetrahydrobiopterin); PAH, phenylalanine hy
nine; Tyr, L-tyrosine
⇑ Corresponding author. Fax: +82 55 336 7706.
E-mail address: mbyspark@inje.ac.kr (Y.S. Park).a b s t r a c t
We have studied the regulatory function of Dictyostelium discoideum Ax2 phenylalanine hydroxylase
(dicPAH) via characterization of domain structures. Including the full-length protein, partial pro-
teins truncated in regulatory, tetramerization, or both, were prepared from Escherichia coli as his-
tag proteins and examined for oligomeric status and catalytic parameters for phenylalanine. The
proteins were also expressed extrachromosomally in the dicPAH knockout strain to examine their
in vivo compatibility. The results suggest that phenylalanine activates dicPAH, which is functional
in vivo as a tetramer, although cooperativity was not observed. In addition, the results of kinetic
study suggest that the regulatory domain of dicPAH may play a role different from that of the
domain in mammalian PAH.
Structured summary of protein interactions:
dicPAH and dicPAH bind by molecular sieving (View Interaction: 1, 2, 3, 4)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Phenylalanine hydroxylase (PAH; EC 1.14.16.1) is an enzyme
that catalyzes the conversion of L-phenylalanine (Phe) to L-tyrosine
(Tyr) in the presence of L-erythro-tetrahydrobiopterin (BH4) and
molecular oxygen [1]. PAH is expressed high both in the liver
and kidney, where the enzyme is responsible for preventing accu-
mulation of dietary Phe and producing Tyr as a precursor for cate-
cholamines, respectively. PAH mutations in human are notorious
for phenylketonuria resulting in irreversible mental disability
without dietary restriction of Phe very soon after birth [2]. More
than 600 disease-causing mutations are known to date with vary-
ing degrees of hyperphenylalaninemia [2]. Phenylketonuria is well
established as a misfolding disease, because most missense muta-
tions result in misfolding of PAH, which causes increased protein
turnover in vitro and probably in vivo [3].chemical Societies. Published by E
DH4, tetrahydrodictyopterin
droxylase; Phe, L-phenylala-Human PAH consists of three domains, N-terminal regulatory,
central catalytic, and C-terminal tetramerization domains and ex-
ists in pH-dependent equilibrium of dimeric and tetrameric forms
[4]. In contrast, bacterial and plant PAHs contain only catalytic do-
main and are active as monomers [1,5,6]. Mammalian PAH is allos-
terically regulated by the substrate Phe. The regulatory domain in
mammalian PAH is involved in regulation by positive cooperativity
for Phe, coping with increased Phe from diet [1]. PAH is also known
fromDictyostelium discoideumAx2. Likemammalian PAH, theDicty-
ostelium PAH (dicPAH) carries three domains, where the catalytic
and tetramerization domains share higher homologywithmamma-
lian proteins than the regulatory domain. The dicPAHwas shown to
be devoid of the characteristic regulatory mechanism of mamma-
lian PAH [7]. Nevertheless, we were curious about the evolutionary
reason of the existence of domain structures in dicPAH. Dictyosteli-
um is a social amoeba that grows on bacteria in nature and develops
under starvation conditions.Dictyostelium is deﬁcient in Tyr biosyn-
thesis and depends absolutely on PAH activity for vegetative
growth in a minimal medium [8]. Therefore, it was speculated that
dicPAH may also need to be controlled to maintain properly both
Phe and Tyr levels for proliferation in nature. In order to look for
the putative regulatory function of dicPAH we have studied herelsevier B.V. All rights reserved.
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ramerization domains in dicPAH via in vitro and in vivo studies.
2. Materials and methods
2.1. Cell growth and development
D. discoideum Ax2 cells were grown at 22 C in HL5 medium
(15.4 g glucose, 7.15 g yeast extract, 14.3 g protease peptone,
0.485 g KH2PO4, 1.28 g Na2HPO412H2O, pH 6.5, per liter) with
100 lg/ml streptomycin sulfate and 100 U/ml benzylpenicillin
potassium [9]. Dictyostelium cells were also grown in a chemically
deﬁned FM medium devoid of Tyr [10].
2.2. Expression and puriﬁcation of recombinant dicPAHs
Total RNA was extracted from vegetative cells by using TRI re-
agent (Molecular Research Center. Inc). cDNA was prepared from
2 lg of total RNA by using QIAGEN OneStep RT-PCR Kit (QIAGEN).
The full-length ORF sequence of dicPAH (WT) was ampliﬁed by PCR
from the cDNA using the primer pair 50-gctagcatggaatctaaca-
caaattctcaag-30 (WT-F) and 50-ggatccttaagctttaagttttgaaattgca-30
(WT-R). The ampliﬁed DNA was cloned into a pGEM-T vector. Sub-
sequently, three mutant dicPAHs depleted of regulatory domain,
tetramerization domain, and both (CT, RC, and C, respectively)
were ampliﬁed by PCR from the cloned WT sequence. CT sequence
was ampliﬁed using 50-gctagcatggtaaaagctacaacccttcaagaaa-30 (CT-
F) and WT-R. RC sequence was ampliﬁed using WT-F and 50-
gcgctcgagttatttgttatcaagtatttcaattgattg-30 (RC-R). C sequence was
ampliﬁed using CT-F and RC-R. The ampliﬁed DNAs cloned into
pGEM-T vector were digested with NheI/BamHI (WT and CT) or
NheI/XhoI (RC and C) and cloned subsequently into the correspond-
ing restriction sites of pET-28b. PCR ampliﬁcations were performed
with Pfu polymerase in 1 reaction buffer, 1.5 mM MgCl2, 200 lM
dNTPs, 0.2 lM each of primer pairs, and templates, under the fol-
lowing conditions: 4 min at 95 C, followed by 30 cycles of 94 C
for 1 min, 57–61 C for 1 min, and 72 C for 1 min, and a ﬁnal poly-
merization at 72 C for 10 min. DNA sequences were conﬁrmed by
sequencing.
The plasmids were transformed into BL21(DE3) pLysS compe-
tent cells. Escherichia coli BL21(DE3)/pLysS transformants were in-
duced with 0.05–0.2 mM isopropyl-b-D-thiogalactopyranoside and
were cultured for 8 h at 22 C. The recombinant proteins contain-
ing N-terminal 6xHis-tag were puriﬁed by chromatography on
Ni-nitrilotriacetic acid gel according to the instructions of the man-
ufacturer (Qiagen). The proteins were eluted with 250 mM imidaz-
ole, dialyzed against a mixture of 20 mM Tris–HCl (pH 7.5) and 30%
(vol/vol) glycerol, and stored in aliquots at 70 C until use. Puriﬁ-
cation of the proteins was conﬁrmed by electrophoresis on a SDS–
polyacrylamide gel.
2.3. Creation of dicPAH knockout mutant
The knockout mutant (pah) was created by insertional muta-
genesis. To make a disruption construct the DNA sequence of dic-
PAH spanning exon 1 and exon 3 (1.1 kb) was ampliﬁed into two
parts by PCR using two primer pairs (upper forward, 50-gaattgaat-
caagaccatcaaaaaccg-30; upper reverse, 50-ggatccatctgaagttaaatct
gatcccatttctaatact-30; lower forward, 50-aagcttcaggtgcttcagatccagttt
acagagaa-30; lower reverse, 50-acaatctggttctggtgtatataatggtacgg-30).
The ampliﬁed DNA fragments were cloned separately into pGEM-T
vectors. The upper fragmentwas digestedwithNot I/BamHI and the
lower with Eco RI. They were ligated with the 1.4 kb blasticidin
resistance gene (bsr) cassette, which was previously digested from
pUCBsrDBam plasmid [11] with Bam HI/Hin dIII. The ligated DNA,in which the bsr cassette is positioned between the upper and the
lower fragments, was ampliﬁed by PCR using the upper forward
and the lower reverse primers. The ampliﬁed DNA was puriﬁed
and then used for transformation of Dictyostelium.
Transformation was performed with S phase synchronized
method [12]. Cells were synchronized in S phase by incubation at
9.6 C for 14 h followed by incubation at 22 C for 2.5 h at a density
of 1.0  106 cells/ml in HL5 medium. Cells were harvested by cen-
trifugation at 350g for 3 min and resuspended in electroporation
buffer (10 mM NaPO4, 50 mM sucrose, pH 6.1) at a density of
5  107 cells/ml. An aliquot (500 ll) of the cell suspension was
mixed with 10 lg of DNA and electroporated with a Transfector
800 (BTX) (0.85 kV, 2 times). After cooling on ice for 5 min, cells
were transferred to Petri dish containing 20 ml of HL5 medium
and incubated at 22 C for 24 h. The medium was supplemented
with 0.4 lg of blasticidin S and changed every 3 days. Alive clones
in the selection medium were isolated between 7 and 10 days.
Colonial selection of transformant was accomplished by plating
the cells on 5LP agar (0.5% lactose and 0.5% Difco peptone with
1.5% agar) with E. coli BL21(DE3). The colony cells were ﬁnally
inoculated into Petri dish containing 20 ml of HL5.
2.4. Expression of dicPAHs in pah strain
To rescue the PAH knockout mutant with the various forms of
dicPAH, the encoding DNA sequences were cloned into p18V plas-
mid (a gift of Prof. Wolfgang Nellen in Kassel University, Germany)
[13]. The full-length and truncated dicPAH sequences were ampli-
ﬁed from the cloned ORF sequence by PCR. WT sequence was
ampliﬁed using 50-ggatccatggaatctaacacaaattctcaagg-30 (WT-F)
and 50-ggtaccttaagctttaagttttgaaattgcatc-30 (WT-R). RC sequence
was ampliﬁed using WT-F and 50-ggtaccttatttgttatcaagtatttcaatt-
gattga-30 (RC-R). CT sequence was ampliﬁed using 50-agatctatggta
aaagctacaacccttcaagaaa-30 (CT-F) and WT-R. C sequence was
ampliﬁed using CT-F and RC-R primers. The ampliﬁed DNAs were
cloned into pGEM-T vector and subsequently into pV18 as Bam-
HI/KpnI (WT and RC) and BglII/KpnI (CT and C) restriction
fragments.
The plasmids were conﬁrmed by DNA sequencing and trans-
formed into pah cells following the procedure described above
(Section 2.3) except that G418 was used for selection of
transformant.
2.5. Assay of PAH activity
PAH assay was carried out at 37 C for 10 min in a volume of
50 ll containing 100 mM Tris–HCl (pH 7.5), 2 mM Phe, 100 units
catalase, 5 mM DTT, 0.4 mM DH4, and an aliquot of enzyme solu-
tion [7]. Kinetic analysis was performed with 3 lg of puriﬁed pro-
tein in the same reaction conditions. The reaction mixture was
mixed with an equal volume of 5% (v/v) TCA solution and centri-
fuged for 10 min to discard proteins. The supernatant was analyzed
by HPLC using a Inertsil ODS-3 C18 column eluted with 40 mM so-
dium acetate (pH 3.5) at a ﬂow rate of 1 ml/min. Tyr peak was de-
tected by ﬂuorescence at 290 nm/340 nm (ex/em).
Tomeasure cellular PAH activity crude extractwas prepared fresh
from Dictyostelium cells (1 107) dissolved in 10 mM Tris–HCl (pH
7.0), 1 mM DTT, and 1 mM PMSF. The cells were disrupted by three
cycles of freeze-thawing and centrifuged to remove precipitates.
The supernatant was desalted using Sephadex G-25 spin column.
2.6. Miscellaneous methods
SDS–PAGE was performed on denaturing conditions with a 10%
polyacrylamide gel. Protein was measured by the Bradford method
Fig. 2. Size-exclusion chromatography of recombinant dicPAHs. The chromatogra-
phy was performed with 500 lg each of the puriﬁed proteins on a column of
Superdex 200 (10/300) using a FPLC system at 0.4 ml/min in 50 mM phosphate
buffer (pH 7.0), 150 mM NaCl. Open circles in the inset graph show the calculated
molecular masses (kD): (1) 230.7 (tetrameric WT); (2) 156.8 (tetrameric CT); (3)
109.1 (dimeric WT); (4) 88.9 (dimeric RC); (5) 29.9 (monomeric C). The expected
molecular masses (kD) of the corresponding proteins are 223.1, 171.4, 111.6, 103.6,
and 39.5, respectively. Closed circles are calibration standards: thyroglobulin,
apoferritin, albumin, carbonic anhydrase, ribonuclease, cytochrome c, aprotinin, and
vitamin b12.
Table 1
Kinetic parameters for Phe.
Protein Non-preincubation Preincubation
Km (mM) kcat (s1) Km (mM) kcat (s1)
WT 0.637 ± 0.114 6.62 ± 0.42 0.287 ± 0.065 8.93 ± 0.51
CT 0.725 ± 0.271 2.24 ± 0.30 0.213 ± 0.036 3.72 ± 1.31
RC 0.189 ± 0.028 1.53 ± 0.04 0.303 ± 0.081 3.01 ± 0.18
C 0.211 ± 0.053 1.49 ± 0.08 0.214 ± 0.045 2.91 ± 0.13
Kinetic parameters (mean ± S.D.) were determined from non-linear regression plots
using the PRISM program (GraphPad Software, USA). Assay was performed with
0–4 mM phenylalanine and 0.2 mM DH4 in the standard conditions. Preincubation
was performed with 0–4 mM Phe for 5 min. kcat values are per active site.
3598 H.-L. Kim et al. / FEBS Letters 586 (2012) 3596–3600using bovine serum albumin as a standard. Unless stated other-
wise, data were obtained from at least three independent experi-
ments and described as mean ± S.D. values.
3. Results and discussion
3.1. Oligomeric status of recombinant dicPAHs
Including the full-length dicPAH (WT), the three truncated dicP-
AHs depleted of regulatory, tetramerization, or both domains (CT,
RC, and C, respectively) (Fig. 1A) were expressed in E. coli and puri-
ﬁed as soluble His-tag proteins (Fig. 1B). The oligomeric status of
the proteins was determined by size-exclusion chromatography
(Fig. 2). In accordance with their human counterparts [14], WT
was eluted as both tetrameric and dimeric forms, while CT and
RC were eluted as tetrameric and dimeric forms, respectively, sup-
porting evolutionary conservation of domain structures in dicPAH.
The catalytic domain containing residues 103–428 of human
PAH forms a dimer probably due to dimerization motif [14,15].
In spite of carrying a sequence highly homologous to the dimeriza-
tion motif (Fig. 1A and Supplementary data Fig. 1), however, C was
eluted as a monomer like a bacterial PAH [5]. This may imply a
loose association between catalytic domains in tetrameric dicPAH.
3.2. Kinetic analyses of recombinant dicPAHs
Dictyostelium produces not only BH4 but also its isomer DH4,
which is much more abundant than BH4 in the organism [16]. A
previous kinetic study suggested DH4 as a cofactor for dicPAH
[7], although the competitive role of BH4 in vivo remains contro-
versial [8]. Since the cellular abundance of DH4 indicates that the
cofactor may not be a limiting factor for PAH catalysis in Dictyoste-
lium, we focused on determining kinetic parameters for Phe (Table
1). Although we could not observe cooperativity in the non-linear
regression plot of WT protein (data not shown), consistent with the
previous report [7], there were remarkable differences in the
kinetic parameters between the tetrameric (WT and CT) and the
dimeric/monomeric (RC and C) forms.
The Km values obtained without preincubation were more than
three-fold higher for WT and CT than those for RC and C. In con-Fig. 1. Preparation of recombinant dicPAHs. (A) Schematic diagram of the
constructs made in this study. (B) Electrophoretic behavior of recombinant proteins
puriﬁed from E. coli. The 10% SDS–polyacrylamide gel was stained with Coomassie
blue. Molecular weight markers are shown on the left, with their masses in kDa. The
deduced masses including 6xHis-tag were 55.8 kDa (WT), 51.8 kDa (CT), 42.8 kDa
(RC), and 39.5 kDa (C).junction with the oligomeric status of the proteins (Fig. 2), it looks
as if the dimeric/monomeric forms were relieved from structural
constraints of substrate-binding in tetrameric forms. In addition,
preincubation with Phe lowered the Km values of WT and CT to
the level similar to those of RC and C. The results suggest Phe-in-
duced activation of the tetrameric forms, putatively via a mecha-
nism involving conformational changes. The activation by Phe,
however, seems to be not mediated by the regulatory domain, be-
cause the domain is absent in CT. This is totally different from the
regulation of mammalian PAH, which is well-known to be acti-
vated by the removal of regulatory domain due to its inhibitory
function [17,18].
Another remarkable difference seen in the non-preincubation
data was the kcat value, which was at least three-fold higher for
WT than for others. This ﬁnding provides an insight into the role
of regulatory domain. Considered the structural and kcat differences
betweenWT and CT, it appears that the regulatory domain contrib-
utes to enhancing kcat in association with the catalytic domain. In
addition, since RC is also poor in kcat, the regulatory domain may
be functional only in the tetrameric forms. Preincubation exhibited
stimulatory effect on kcat not only forWT (1.3-fold) but also for oth-
ers (1.7- to 2.0-fold). This seemingly non-speciﬁc stimulatory effect
supports once again that the function of regulatory domain might
be independent from the activation by Phe. We should, however,
make it sure in the future if the regulatory domain of dicPAH binds
Fig. 3. Complementation of pah strain. (A) Agarose gel electrophoresis of DNA products ampliﬁed by PCR from the genomic DNAs of wild type (Ax2) and PAH knockout
mutant (pah). (B) Vegetative growth of rescued pah cells in a minimal medium. The values represent means of three independent experiments performed in the same
conditions. Error bars are omitted for reasons of clarity.
Fig. 4. Protein stability of dicPAHs. (A) PAH activity measured in the crude extract. The crude extract was prepared fresh from the cells harvested after 24 h of culture. PAH
activity was determined using 200 lg of protein. (B) Time course of PAH activity in the mixture of recombinant dicPAHs and the cellular extract of pah. One hundred
micrograms each of recombinant dicPAHs puriﬁed from E. coliwas mixed with an equal amount of the crude extract (200 lg) prepared from pah cells, incubated at 37 C for
the indicated times, and assayed for the residual PAH activity.
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Phe binding site at the regulatory domain of full-length protein, in
spite of lacking cooperativity for Phe [19]. The Phe binding site in-
volves the GA(S)L/IESRP motifs, which are also conserved in dicPAH
(Supplementary data Fig. 1).
3.3. Functional complementation and protein stability
In order to examine in vivo compatibility of the truncated dicP-
AHs, we ﬁrst created a knockout mutant disrupted in the PAH gene
by insertional mutagenesis (Fig. 3A). The resulting knockout mu-
tant (pah) showed a 2.5 kb DNA fragment harboring bsr insert
in the PAH gene, instead of a 1.1 kb wild type DNA (Fig. 3A). The
pah strain did not proliferate in FM medium (Fig. 3B), proving
not only the disabled gene but also essential role of PAH in Dicty-
ostelium. The pah strain was rescued by overexpression of dicPAH
proteins via expression vector and examined for vegetative growth
in FM medium (Fig. 3B). Both pah[WT] and pah[CT] cells recov-
ered normal growth, whereas pah[RC] did partially. pah[C] did
not show growth like pah.
Since the vegetative growth of Dictyostelium in FM medium was
known to depend on PAH activity [8], the activity was determined
in the crude extract (Fig. 4A). As expected, compared with those inpah[WT] and pah[CT] cells, the activity was much low in pah[RC]
and was barely detectable in pah[C]. The result suggested loss of
function of the truncated dicPAHs due to protein instability in vivo,
similar to that known in human mutant PAHs [3], because RC and
C proteins were active as much as CT in vitro (Table 1). In order to
prove this, each of the recombinant dicPAHs puriﬁed from E. coli
was incubated with the crude extract of pah cells and assayed for
the residual activities (Fig. 4B). ComparedwithWTprotein,which re-
mained active for 1 h, truncated proteins were inactivated progres-
sively in a time-dependent manner. Remarkably, the activity of C
protein disappeared near completely after 1 h, while tetrameric CT
protein was relatively stable. In the presence of 1 mMPMSF, a serine
protease inhibitor, the proteins remained active after 1 h (data not
shown), ﬁnally proving that the instability of the truncated dicPAHs
is due to rapid turnover in vivo. Therefore, it is clear that dicPAH is
functional as a tetramer in vivo.
4. Conclusions
In this study, the oligomeric status and kinetic parameters
determined for the full-length and truncated dicPAH proteins pro-
vided a decisive insight into the structure and function of domain
structures. Complementation study also conﬁrmed functional
3600 H.-L. Kim et al. / FEBS Letters 586 (2012) 3596–3600integrity of dicPAH as a tetramer in vivo. The results suggest that
tetrameric dicPAH is activated by its substrate Phe through a pro-
cess where the regulatory domain functions differently from that
of human PAH.
Although cooperativity was not observed in this study, we spec-
ulate that Phemay induce conformational changes of dicPAH from a
low afﬁnity to a high afﬁnity form. The loose interaction between
catalytic domains of dicPAH, as described in Section 3.1, may facil-
itate the conversionwithoutmobilization of the regulatory domain,
which independently improves turnover rate via interaction with
the catalytic domain. We could not observe, however, Phe-induced
changes in oligomeric status when the proteins preincubated with
or without Phe were analyzed by size-exclusion chromatography
(data not shown). Recently we determined the 3D structure of RC
protein in complexwith dihydrobiopterin and FeIII [20] and are cur-
rently expanding the crystallography study into the other truncated
proteins as well as the full-length one to clarify the putative alloste-
ric regulation of dicPAH.
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